Literature DB >> 12764364

Donor leukocyte infusions in acute myelogenous leukemia.

D L Porter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12764364     DOI： 10.1038/sj.leu.2402950

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Authors:  Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

Review 2.  Cellular immune therapy for refractory cancers: novel therapeutic strategies.

Authors:  Karen K Ballen; Gerald Colvin; Bimalangshu R Dey; David Porter; Peter Westervelt; Thomas R Spitzer; Peter J Quesenberry
Journal:  Exp Hematol       Date:  2005-12       Impact factor: 3.084

3.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

Review 4.  Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review.

Authors:  Karen K Ballen; Gerald Colvin; David Porter; Peter J Quesenberry
Journal:  Leuk Lymphoma       Date:  2004-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.